Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Status:
RECRUITING

Trial end date:
2030-07-20

Target enrollment:

Participant gender:

The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.

PHASE3

Amgen

avacopan